The Architecture of Gene Regulatory Variation Across Multiple Human Tissues: the MuTHER Study
Overview
Authors
Affiliations
While there have been studies exploring regulatory variation in one or more tissues, the complexity of tissue-specificity in multiple primary tissues is not yet well understood. We explore in depth the role of cis-regulatory variation in three human tissues: lymphoblastoid cell lines (LCL), skin, and fat. The samples (156 LCL, 160 skin, 166 fat) were derived simultaneously from a subset of well-phenotyped healthy female twins of the MuTHER resource. We discover an abundance of cis-eQTLs in each tissue similar to previous estimates (858 or 4.7% of genes). In addition, we apply factor analysis (FA) to remove effects of latent variables, thus more than doubling the number of our discoveries (1,822 eQTL genes). The unique study design (Matched Co-Twin Analysis--MCTA) permits immediate replication of eQTLs using co-twins (93%-98%) and validation of the considerable gain in eQTL discovery after FA correction. We highlight the challenges of comparing eQTLs between tissues. After verifying previous significance threshold-based estimates of tissue-specificity, we show their limitations given their dependency on statistical power. We propose that continuous estimates of the proportion of tissue-shared signals and direct comparison of the magnitude of effect on the fold change in expression are essential properties that jointly provide a biologically realistic view of tissue-specificity. Under this framework we demonstrate that 30% of eQTLs are shared among the three tissues studied, while another 29% appear exclusively tissue-specific. However, even among the shared eQTLs, a substantial proportion (10%-20%) have significant differences in the magnitude of fold change between genotypic classes across tissues. Our results underline the need to account for the complexity of eQTL tissue-specificity in an effort to assess consequences of such variants for complex traits.
Pudjihartono M, Golovina E, Fadason T, OSullivan J, Schierding W Mol Oncol. 2024; 18(4):1031-1048.
PMID: 38308491 PMC: 10994230. DOI: 10.1002/1878-0261.13599.
Everman E, Macdonald S G3 (Bethesda). 2024; 14(3).
PMID: 38262701 PMC: 11021028. DOI: 10.1093/g3journal/jkae015.
Margaritte-Jeannin P, Vernet R, Budu-Aggrey A, Ege M, Madore A, Linhard C Allergy Asthma Immunol Res. 2023; 15(6):779-794.
PMID: 37957795 PMC: 10643854. DOI: 10.4168/aair.2023.15.6.779.
Gedik H, Peterson R, Riley B, Vladimirov V, Bacanu S Complex Psychiatry. 2023; 9(1-4):130-144.
PMID: 37588130 PMC: 10425719. DOI: 10.1159/000530223.
Wang Y, Ding Y, Liu S, Wang C, Zhang E, Chen C Am J Hum Genet. 2023; 110(9):1574-1589.
PMID: 37562399 PMC: 10502736. DOI: 10.1016/j.ajhg.2023.07.008.